Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Nutrition (Burbank, Los Angeles County, Calif.)|July 3, 2002
Influence of apolipoprotein E phenotype on metabolism of lipids and apolipoproteins after plant stanol ester ingestion in Japanese subjectsKazuo Ishiwata, Yasuhiko Homma, Toshitsugu Ishikawa, et al.Nutrition (Burbank, Los Angeles County, Calif.)|April 8, 2003
Decrease in plasma low-density lipoprotein cholesterol, apolipoprotein B, cholesteryl ester transfer protein, and oxidized low-density lipoprotein by plant stanol ester-containing spread: a randomized, placebo-controlled trialYasuhiko Homma, Ikuo Ikeda, Toshitsugu Ishikawa, et al.Journal of Cardiology|November 12, 2010
Long-term event monitoring study of fluvastatin in Japanese patients with hypercholesterolemia: Efficacy and incidence of cardiac and other events in elderly patients (≥ 65 years old)Hiroshige Itakura, Noriaki Nakaya, Tadashi Kusunoki, et al.Current Therapeutic Research, Clinical and Experimental|March 28, 2014
Increased risk for cardiovascular outcomes and effect of cholesterol-lowering pravastatin therapy in patients with diabetes mellitus in the pravastatin anti-atherosclerosis trial in the elderly (PATE)Toshitsugu Ishikawa, Hideki Ito, Yasuyoshi Ouchi, et al.Journal of Cardiology|December 26, 2012
Risk reductions for cardiovascular disease with pravastatin treatment by dyslipidemia phenotype: a post hoc analysis of the MEGA StudyMasato Nishiwaki, Katsunori Ikewaki, Makoto Ayaori, et al.Journal of Atherosclerosis and Thrombosis|September 1, 2010
Effects of supervised aerobic exercise training on serum adiponectin and parameters of lipid and glucose metabolism in subjects with moderate dyslipidemiaHiroshi Yoshida, Toshitsugu Ishikawa, Michiko Suto, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|August 30, 2008
The relationship between the effect of pravastatin and risk factors for coronary heart disease in Japanese patients with hypercholesterolemiaToshitsugu Ishikawa, Kyoichi Mizuno, Noriaki Nakaya, et al.Current Therapeutic Research, Clinical and Experimental|March 29, 2014
Influences of age, sex, and LDL-C change on cardiovascular risk reduction with pravastatin treatment in elderly Japanese patients: A post hoc analysis of data from the Pravastatin Anti-atherosclerosis Trial in the Elderly (PATE)Yasuyoshi Ouchi, Yasuo Ohashi, Hideki Ito, et al.Journal of Atherosclerosis and Thrombosis|September 19, 2002
Sweet elements of Siraitia grosvenori inhibit oxidative modification of low-density lipoproteinEiichiro Takeo, Hiroshi Yoshida, Norio Tada, et al.Pageof 1